What disease areas does Abbvie focus on?

Abbvie is dedicated to addressing a wide range of disease areas through its innovative research and development efforts. The company primarily focuses on immunology, oncology, neuroscience, and virology. In the immunology space, Abbvie investigates treatments for conditions such as rheumatoid arthritis, inflammatory bowel disease, and psoriasis. For oncology, the company explores therapies aimed at various types of cancer, focusing on improving patient outcomes. In neuroscience, Abbvie is engaged in research for neurodegenerative disorders, including Alzheimer’s disease and multiple sclerosis. The company also has a commitment to virology, particularly in the development of therapies for hepatitis C and other viral infections. Furthermore, Abbvie works on other therapeutic areas, ensuring that they remain responsive to emerging healthcare challenges. For those seeking specific information on Abbvie’s latest projects or developments in these disease areas, checking their official website can provide updated details.